Breaking
● GLP-1 trial shows 34% reduction in cardiovascular events over 5 years ● Senolytics drug enters Phase III — first human trial results expected Q1 2027 ● FDA fast-tracks CRISPR base-editing therapy for sickle cell disease ● Longevity biotech index up 12% YTD as institutional capital accelerates ● AI diagnostic platform achieves 97.2% accuracy in early-stage pancreatic cancer detection ● Harvard study links CGM use to 23% lower all-cause mortality in non-diabetics
Impact Health Magazine
Futuristic medical technology
Home
Technology & Innovation

The Tools Rewriting Human Biology

From AI-powered diagnostics to precision biohacking gear — the technology stack of the world's most optimized humans.

$47B

Global digital health market in 2026

312%

Growth in AI diagnostics adoption since 2022

2.4×

Faster disease detection with AI vs. standard screening

Featured Articles
The AI That Detected My Cancer Before My Doctor Did
AI Diagnostics

The AI That Detected My Cancer Before My Doctor Did

A first-person account of how a consumer-grade AI screening tool flagged an early-stage malignancy — and what it means for the future of preventive care.

Dr. Sarah Chen·Sep 2026·9 min read
Inside the $80,000 Home Biohacking Lab
Biohacking Gear

Inside the $80,000 Home Biohacking Lab

From hyperbaric chambers to continuous biomarker panels — we tour the setups of the world's most committed self-optimizers.

Marcus Webb·Aug 2026·7 min read
CRISPR Enters the Clinic: What the First Human Trials Tell Us
Future of Medicine

CRISPR Enters the Clinic: What the First Human Trials Tell Us

Gene editing has moved from the lab bench to the hospital bed. Here's what the early data reveals — and what it doesn't.

Dr. Priya Nair·Aug 2026·11 min read